Page 372 - Bloedstollig en bloedingsneiging

360 Bloedstolling en bloedingsneiging
to hemostasis - Annals of the New York Academy of Sciences, v. 370 (New York, N.Y.: New York Academy of Sciences, 1981); St. Douglas, ‘Coagulation history, Oxford 1951-1953’, British journal of haematology 107 (1999), 22-32; Ch.A. Owen, W.L. Nichols en E.J. Walter Bowie, A history of blood coagulation (Rochester, Minn.: Mayo Foundation for Medical Education and Research, 2001); P.L.F. Giangrande, ‘Six characters in search of an author: The history of the nomenclature of coagulation factors’, British journal of haematology 121 (2003), 703-12.
Hoofdstuk II
ii–1: R.G. Macfarlane, ‘The blood coagulation system’, in: F.W. Putnam (red.), The plasma proteins - vol. 1: Isolation, characterization, and function; vol. 2: Biosynthesis, metabolism, alterations in disease (New York: Academic Press, 1960), pp. 137-83, met name p. 137.
ii–2: L.M. Tocantins (red.), The coagulation of blood; methods of study [Prepared with the help and under the sponsorship of the Panel on Blood Coagulation of the Committee on Medicine and Surgery of the National Academy of Sciences, National Research Council] (New York: Grune & Stratton, 1955), pp. 229-30.
ii–3: H.C. Hemker, ‘De bloedstolling’, in: P.F.W. Strengers en W.G. van Aken (red.), Bloed: Van magie tot wetenschap (Maastricht: Natuur & Techniek, 1994), pp. 70-89, met name p. 75.
ii–4: C.A. Pekelharing, ‘De physiologie in Nederland in de laatste halve eeuw’, Nederlands tijdschrift voor geneeskunde i (1907), 8-19; P. Morawitz, ‘Die Chemie der Blutgerinnung’, Ergebnisse der Physiologie 4 (1905), 307-422; P. Morawitz, The chemistry of blood coagulation (Springfield, Ill.: Charles C. Thomas, 1958).
ii–5: Chr.W. Hemker, De ontdekking van het prothrombine (Amsterdam: Ronald Meesters, 1981).
ii–6: C.A. Pekelharing, Voordrachten over weefselleer (Haarlem: De Erven F. Bohn, 1917 2), p. 1.
ii–7: Zie ook E. Bächli, ‘History of tissue factor’, British journal of haematology 110 (2000), 248-55.
ii–8: E.A. Loeliger, In de greep van de protrombinetijd: Een persoonlijke visie op 45 jaar orale antistollingsbe- handeling (Leiden: E.J. Brill, 1985), 63-4.
ii–9: A.J. Quick, M. Stanley-Brown en F.W. Bancroft, ‘A study of the coagulation defect in hemophilia and in jaundice’, American journal of medical sciences 190 (1935), 501-11.
ii–10: A.J. Quick, ‘On the constitution of prothrombin’, American journal of physiology 140 (1943), 212-20. ii–11: E.M. Ebel, The Quick tests: The life and work of dr. Armand J. Quick (Blacksburg, VI: Pocahontas Press Inc., 1995).
ii–12: P. Morawitz, ‘Die Chemie der Blutgerinnung’, Ergebnisse der Physiologie 4 (1905), 307-422; P. Morawitz, The chemistry of blood coagulation (Springfield, Ill.: Charles C. Thomas, 1958), pp. 126-7.
ii–13: Het onderscheid direct versus indirect werkzaam wordt bijvoorbeeld gehanteerd in: H.K. Kettenborg, E.A. Loeliger en O. Planten, ‘Ervaringen met het indirect werkende anticoagulans Marcoumar bij de trombosedienst’, Nederlands tijdschrift voor geneeskunde 102 (1958), 2269-75.
ii–14: W.H. Howell, ‘Theories of blood coagulation’, Physiology reviews 15 (1935), 435-70; J. Mclean, ‘The discovery of heparin’, Circulation 19 (1959), 75-8; J.A. Marcum, ‘The origin of the dispute over the discovery of heparin’, Journal of the history of medicine and allied sciences 55 (2000), 37-66.
ii–15: M. Verstraete, ‘Heparin and thrombosis: A seventy year long story’, in: G.G. Neri Serneri (ed.), Heparin: Present and future - Proceedings of the symposium on heparin, Florence, March 28-31, 1990 (Basel: Karger, 1990), pp. 4-11.
ii–16: J. Kiss, ‘Chemical structure of heparin’, in: V.V. Kakkar en D.P. Thomas (red.), Heparin: Chemistry and clinical usage - Proceedings of an International Heparin Symposium held at the King’s College Hospital Medical School, July 18-19, 1975 (London: Academic Press, 1976), pp. 3-20, met name p. 11.
ii–17: Anonymus, Anticoagulentia in de huisartsenpraktijk (Haarlem: Propharma N.V., 1960), p. 11.
ii–18: K.P. Link, ‘The discovery of dicoumarol and its sequels’, Circulation 19 (1959), 97-107; P. Griminger, ‘Vitamin K antagonists: The first 50 years’, Journal of nutrition 117 (1987), 1325-9.
ii–19: Anonymus, Anticoagulentia in de huisartsenpraktijk (Haarlem: Propharma N.V., 1960), p. 12.
ii–20: Zie ‘Henrik Dam’, in: Giulio Gabbiani (red.), Reflections on biologic research [Dedicated to Hans Selye, on the occasion of his 60th birthday] (St. Louis, Miss: Warren H. Green, Inc., 1967), pp. 27-31.
ii–21: Vide supra.
ii–22: Zie ook het onderwerp ‘fibrinolyse’ in: P. Morawitz, The chemistry of blood coagulation (Springfield, Ill.: Charles C. Thomas, 1958), pp. 93-5.
ii–23: P.L.F. Giangrande, ‘Six characters in search of an author: The history of the nomenclature of coagulation factors’, British journal of haematology 121 (2003), 703-12, met name p. 703. Giangrande schrijft: ‘This is primarily an account of how the current nomenclature of the blood coagulation factors came into being, but it is also the more personal story of six patients whose names are still associated with several important haemostatic proteins: Christmas (factor IX), Stuart and Prower (factor X), Hageman (factor XII), Fletcher (prekallikrein) and Fitzgerald (high-molecular-weight kininogen).’
ii–24: A.J. Patek en F.H.L. Taylor, ‘Hemophilia: II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood’, Journal of clinical investigation 16 (1937),